Acute left ovarian vein thrombosis following percutaneous renal biopsy: A case report Authors: William Collis, Michael Shumaker, Eric Van Bogaert Published: 2026 ABSTRACT AbstractOvarian vein thrombosis is a previously unreported complication of percutaneous renal biopsy. We present the case of a 42-year-old female with systemic lupus erythematosus who developed acute left ovarian vein thrombosis three days after ultrasound-guided left renal biopsy performed to evaluate new-onset proteinuria. The patient presented to the emergency department with lower abdominal pain, generalized weakness, fatigue, and heart palpitations. Computed tomography with intravenous contrast revealed an anatomic variant left ovarian vein posterolateral to the left kidney with acute thrombosis. The pathogenesis is attributed to endothelial injury of the ovarian vein during the biopsy procedure and increased risk of thrombosis due to lupus-associated hypercoagulability. After exclusion of hemorrhagic and other common post-biopsy complications, the patient was managed with a three-month course of apixaban following vascular surgery consultation and was discharged in stable condition. This case underscores the importance of preprocedural vascular mapping to identify anatomical variants that may alter procedural risk and predispose to thrombotic complications.Keywords: Percutaneous renal biopsy, Membranous lupus nephritis, Ovarian vein thrombosis, Anatomical variant, Computed tomography, Anticoagulation Introduction Ovarian vein thrombosis (OVT) is a rare form of venous thromboembolism (VTE) that usually occurs because of hypercoagulability associated with other conditions, most frequently cancer, recent pelvic surgery, post-partum state, and infection [1]. Patients with OVT can be asymptomatic or present with abdominal pain and tenderness which can be localized to the side of thrombosis. Diagnosis of OVT can be made using Doppler ultrasound, CT, or MRI [2]. The major complications associated with ovarian vein thrombosis are pulmonary embolism and extension of thrombus into nearby veins, including the renal veins and IVC. Prompt diagnosis and initiation of anticoagulant treatment are essential to reduce the risk of these complications [3]. Although OVT can occur following surgical procedures, it has not been previously reported as a complication of percutaneous renal biopsy. The most frequent complication of renal biopsy is bleeding, which occurs in 2%-3% of patients [4]. VTE after renal biopsy is rare and usually involves the renal veins. In a prospective observational study of 400 renal biopsies, renal vein thrombosis occurred in 1.5% of cases, with the risk being higher when anticoagulation was withheld for the procedure [5]. Preprocedural imaging has been shown to reduce the rate of complications from renal biopsy [4]. Here, we report a case of a 42-year-old woman with systemic lupus erythematosus who developed OVT following percutaneous renal biopsy. We also discuss the risk factors for VTE and highlight the importance of preprocedural imaging to reduce the risk of complications following renal biopsy. Case presentation A 42-year-old female with known systemic lupus erythematosus presented for evaluation of new-onset proteinuria. Preprocedural bilateral renal ultrasound demonstrated a right kidney measuring 13.3 cm in length with an enlarged but nonechogenic cortex and a left kidney measuring 11.7 cm with normal cortex. Neither kidney showed evidence of cysts, stones, or masses. Postvoid residual was less than 50 mL, indicating no significant urinary retention. An ultrasound-guided percutaneous left renal biopsy was performed without immediate complications. Renal tissue pathology demonstrated membranous lupus nephritis, ISN/RPS Class V, EXT2 positive. Three days following the biopsy, the patient presented to the emergency department with lower abdominal pain, generalized weakness, fatigue, and palpitations. On arrival, she was afebrile, normotensive, and mildly tachycardic with normal oxygen saturation on room air. Physical examination revealed mild left costovertebral angle tenderness without erythema, edema, or ecchymosis at the biopsy site. Abdominal tenderness to palpation was present without rigidity or signs of acute abdomen. Laboratory evaluation demonstrated persistent proteinuria without hematuria or evidence of urinary infection. Comprehensive metabolic panel showed creatinine 0.50 mg/dL without electrolyte abnormalities. Complete blood count revealed hemoglobin of 13.9 g/dL, white blood cell counts of 9.5 × 10³/µL, and platelet count of 305 × 10³/µL. Cardiac workup, including electrocardiogram, showed sinus tachycardia. Chest radiograph showed no acute cardiopulmonary process, and troponin level was less than 3 ng/L. Due to the patient's abdominal pain in the setting of recent renal biopsy, CT of the abdomen and pelvis with intravenous contrast was performed. The study demonstrated acute left ovarian vein thrombosis with dilation and a central filling defect (Fig. 1). Notably, the left ovarian vein had an aberrant course along the posterolateral aspect of the left kidney (Fig. 1B). The kidneys and ureters showed no pathologic findings, and there was no evidence of retroperitoneal hemorrhage, renal parenchymal bleed, or surrounding sof tissue stranding. An incidental, uncomplicated right adnexal cyst was noted. No abnormalities were identified in the liver, gallbladder, biliary tree, pancreas, spleen, adrenals, bladder, abdominal wall, bones, or bowels. No free air, free fluid, or fluid collections were present. Axial (A) and coronal-oblique (B) contrast-enhanced CT images show a dilated left ovarian vein with a hypoattenuating central filling defect (yellow arrows). The left ovarian vein has an abnormal course and runs posterolateral to the left kidney (A) and anterolateral to the left psoas muscle (B). The vascular surgery service was consulted and recommended initiation of apixaban 5 mg twice daily for three months. The patient was discharged home from the emergency department in stable condition with outpatient vascular surgery follow-up. No recurrent thrombosis or major bleeding complications occurred during subsequent follow-up. Discussion Image-guided percutaneous renal biopsy is a minimally invasive procedure primarily used to assess the etiology of nephritic and nephrotic syndromes, characterize renal lesions, and evaluate acute renal failure or transplant rejection. The procedure is typically performed with the patient in prone position using ultrasound or CT guidance. Preprocedural imaging with ultrasound, CT, or MRI is essential to assess for anatomical variations or blood vessels that could be at risk during the procedure. The most common complication is bleeding, and standard practice includes post-procedure monitoring for this. In a prospective multicenter study of 5,304 native kidney biopsies, major complications occurred in 5.1% of patients, with the most frequent being a ≥2 g/dL decrease in hemoglobin (2.2%), followed by macrohematuria (1.2%), blood transfusion (1.1%), and gross hematoma (0.9%) [6]. Other recognized complications include pain (4.3%), arteriovenous fistula formation (0.7%), and rarely death (0.06%) [7,8]. Anatomical variants of the ovarian veins are uncommon but clinically significant. The ovarian veins typically drain into the inferior vena cava on the right and the left renal vein on the left, with the right ovarian vein inserting into the IVC in 92% of cases and the left ovarian vein inserting into the left renal vein in 97% of cases [9]. Variant venous anatomy, such as duplication or aberrant course, is a recognized risk factor for procedural complications and may predispose to thrombosis when injured [10,11]. In this case, the left ovarian vein had a variant course posterolateral to the left kidney, placing the vessel directly in the typical biopsy trajectory and at increased risk of injury during the percutaneous biopsy procedure. Preprocedural color Doppler ultrasound can identify vessels at risk and has been shown to prevent bleeding complications in patients with variant renal vascular anatomy [12]. Real-time ultrasound guidance has been associated with significantly fewer complications compared to preprocedure skin-marking techniques, with complication rates of 18% versus 51% in one pediatric study [13]. The pathophysiology of VTE is classically described by Virchow's triad: venous stasis, endothelial injury, and hypercoagulability. In this patient, multiple elements were present, including direct endothelial trauma to the variant ovarian vein during needle passage through the biopsy tract and systemic lupus erythematosus, which is associated with a significantly increased risk of thrombosis. Patients with SLE face an approximately 30% risk of thrombosis post-diagnosis, with both venous and arterial events contributing to mortality [14]. The hypercoagulable state in SLE is multifactorial, involving antiphospholipid antibodies (present in 30%-40% of SLE patients), complement activation, endothelial dysfunction, and platelet abnormalities [15,16]. Lupus anticoagulant demonstrates the strongest association with venous thrombosis (OR: 6.17), followed by anti-β2-glycoprotein I antibodies (OR: 4.77) [17]. Even in the absence of antiphospholipid antibodies, SLE patients remain at elevated thrombotic risk due to shared mechanisms involving autoantibodies, inflammatory cytokines, and endothelial injury [14]. Ovarian vein thrombosis is a rare form of venous thrombosis most commonly associated with the postpartum period (incidence 0.06%-0.18%) and pelvic malignancy (37% of cases) [1,18]. The right ovarian vein is more commonly affected than the left (80%-90% of cases) due to anatomical factors, including its longer course, larger diameter, incompetent valves, and uterine dextrorotation during pregnancy [[18], [19], [20]]. However, anatomical variants may increase risk on the left side in select cases. Other recognized causes include recent abdominal or pelvic surgery, thrombophilia disorders, pelvic inflammatory disease, and vascular injury [3,21,22]. The characteristic imaging appearance on CT includes a dilated ovarian vein (typically & gt; 6-8 mm) with a central hypoattenuating filling defect, best visualized on contrast-enhanced studies [1,23]. MRI demonstrates superior diagnostic performance compared to CT, with the ability to differentiate acute, subacute, and chronic thrombi based on signal characteristics [1]. Complications of OVT include pulmonary embolism (6.5%), extension to the iliac vein (5.9%), inferior vena cava (10.3%), and left renal vein (9.6%) [1]. Post-biopsy abdominal pain requires systematic evaluation to exclude common complications. In this patient, several diagnoses were considered and ruled out. Hemorrhagic complications, the most common post-biopsy adverse event occurring in up to 11% of cases, were excluded by CT demonstrating no retroperitoneal hemorrhage or perirenal hematoma, stable hemoglobin, and absence of macroscopic hematuria [6,7]. Arteriovenous fistula formation (0.7% incidence) was not evident on contrast-enhanced CT [6]. Infection or abscess formation was unlikely given the absence of fever, normal leukocyte count, and lack of fluid collections on imaging [24]. Renal infarction, which would cause wedge-shaped perfusion defects, was not present [25]. The timing of presentation on post-procedure day 3 is notable, as most major bleeding complications (81%-92%) manifest within 24 hours of biopsy, with 43%-52% occurring within the first hour [26,27]. Studies demonstrate that 95-98% of complications are identified within 12-24 hours post-procedure [27,28]. The combination of lower abdominal pain (rather than flank pain), absence of hemorrhagic complications, delayed presentation beyond the typical window for bleeding events, and the patient's underlying hypercoagulable state prompted evaluation for thrombotic complications, leading to the diagnosis of ovarian vein thrombosis. This case identifies an unusual cause of OVT as a complication of percutaneous renal biopsy. To our knowledge, this has not been previously reported in the medical literature. The diagnosis should be considered in the differential of postbiopsy abdominal pain, especially in patients with known vascular variants or hypercoagulable states such as systemic lupus erythematosus. While there are no official guidelines specifically for anticoagulation management of ovarian vein thrombosis, current literature supports initiation of anticoagulation therapy based on principles of venous thromboembolism management [1,3]. Low-molecular-weight heparin, with or without transition to oral anticoagulants, is the most commonly used regimen in published series [1,3]. Direct oral anticoagulants such as apixaban and rivaroxaban represent acceptable alternatives for venous thromboembolism and have been successfully used in OVT cases [[29], [30], [31]]. A typical course of 3 to 6 months is appropriate for provoked thrombosis, consistent with standard VTE management guidelines [29,30,32]. Outcomes are generally favorable when the event is related to a procedural complication rather than spontaneous or cancer-related thrombosis, with recanalization occurring in 70% of patients, recurrent thrombosis in 8%, and major bleeding in only 2% [1,3]. Thrombophilia screening is recommended for nonpregnancy-related cases, as inherited thrombophilic defects are present in 18%-42% of patients with OVT [1,3]. This case demonstrates the importance of identifying variant vascular anatomy before renal biopsy procedures. Preprocedural vascular mapping can identify anatomic variants that alter procedural risk and predispose to post-biopsy complications. Advanced imaging techniques, including color Doppler ultrasound, can be used to assess vascular anatomy and identify vessels at risk during the procedure [12,33,34]. Ultrasound guidance has been independently associated with lower complication rates compared to CT guidance (adjusted OR 8.57 for CT versus ultrasound), likely reflecting both technical factors and appropriate patient selection [35]. The Society of Interventional Radiology supports multimodality imaging for complex cases to optimize procedural safety [34]. Early recognition of post-procedural thrombotic complications through appropriate imaging and prompt initiation of anticoagulation remain essential for favorable patient outcomes. Conclusion This case of left ovarian vein thrombosis following percutaneous renal biopsy highlights the importance of recognizing anatomical vascular variants as potential risk factors for procedural complications. The aberrant course of the left ovarian vein posterolateral to the kidney placed it at increased risk of injury during the biopsy procedure. Combined with the patient's underlying lupus-associated hypercoagulability, this anatomic variant contributed to the development of thrombosis. Clinicians should maintain a broad differential for post-biopsy abdominal pain, systematically excluding hemorrhagic, infectious, and other common complications before considering rarer thrombotic events. Proceduralists should maintain awareness that anatomic variants can predispose to unexpected complications and should consider preprocedural vascular imaging, ideally color Doppler ultrasound, when feasible. Early recognition through appropriate imaging and prompt anticoagulation are essential for optimal outcomes. Patient consent Written informed consent was obtained from the patient for the publication of this case report and accompanying images Footnotes Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References